Category: Autoimmune
Asia Autoimmune
-
Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), Application (Cardiology, Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Technology (Radio immunoassay (RIA), Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions (North America, Asia Pacific, Europe, Latin America, Middle East and Africa)
... Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Fluoro immunoassay (FIA), Chemiluminescence Immunoassay(CLIA) and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceuticals & Biotech Companies, Blood Banks, Academic Research Centers, and Others) and Regions ... Read More
-
Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the ... Read More
-
Sjogren’s Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others (Pain Relief Medication and late phase drug)), by type (Primary and Secondary), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Sjogren’s syndrome is systematic autoimmune disorder which effect the entire body, along ... Read More
-
Disease-Modifying Antirheumatic Drug (DMARD) Market, by Drug Type (Synthetic (sDMARD), (Conventional synthetic (csDMARDs), (Methotrexate, Sulfasalazine, Leflunomide, Hydroxychloroquine and Gold Salts), Targeted synthetic DMARDs (tsDMARDs), Biological DMARDs (bDMARD), (Original DMARDs (boDMARDs), Biosimilar DMARDs (bsDMARDs), (Primary, Secondary and Tertiary) and Others), by Route of Administration (Oral, Parenteral and Others), by Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Systemic Lupus Erythematosus and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Tertiary) and Others), by Route of Administration (Oral, Parenteral and Others), by Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Systemic Lupus Erythematosus and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), ... Read More
-
Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. Immunotherapy is preferable than the old technique as it helps treat a ... Read More
-
In Vitro Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
Asia Pacific Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Asia Pacific monoclonal antibodies market is expected to reach US$ 44,729.7 million by 2028 from US$ 18,344.5 ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
Asia Pacific Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The Asia Pacific (APAC) next-generation antibody market is expected to reach US$ 2,312.68 million by 2028 from US$ 999.49 million in 2021. It is estimated to grow at a CAGR ... Read More
-
Lupus Therapeutic Market, by Disease Type (Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus, and Neonatal Lupus), by Treatment Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Biologics, Antimalarial Drugs, Corticosteroids, and Others {Disease-Modifying Anti-Rheumatic Drugs, Anticoagulants, among others}), by Route of Administration (Oral, Subcutaneous, Intravenous, and Others {Intramuscular, Intradermal, among others}, by End User (Hospitals & Clinics, Diagnostic Laboratories, and Others {Homecare, Specialty Centre, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Anticoagulants, among others}), by Route of Administration (Oral, Subcutaneous, Intravenous, and Others {Intramuscular, Intradermal, among others}, by End User (Hospitals & Clinics, Diagnostic Laboratories, and Others {Homecare, Specialty Centre, among others}), and by Region (North ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
-
Plasma Derived Medicine Market, by Product Type (Albumin, Coagulation factors, Immunoglobulins, and Others), by Indication (Pelvic Inflammatory Disease (PID), Bleeding Disorders, Alpha-1 Antitrypsin Deficiency (AATD), Hereditary Angioedema (HAE), Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Multifocal Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Lyophilization or freeze drying is the process in which the water content ... Read More
Research Assistance
